OXYGENTA PHARMACEUTICAL LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36 INR | +1.12% |
|
-.--% | +15.53% |
| Sales 2022 | 605M 7.26M 9.89M | Sales 2023 | 310M 3.72M 5.07M | Capitalization | 520M 6.23M 8.49M |
|---|---|---|---|---|---|
| Net income 2022 | -6M -71.93K -98.03K | Net income 2023 | -116M -1.39M -1.9M | EV / Sales 2022 | 1.42 x |
| Net Debt 2022 | 520M 6.23M 8.49M | Net Debt 2023 | 679M 8.14M 11.09M | EV / Sales 2023 | 3.87 x |
| P/E ratio 2022 |
-50.1
x | P/E ratio 2023 |
-4.49
x | Employees | 157 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 21.01% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.12% | ||
| 1 month | -7.31% | ||
| 3 months | -0.53% | ||
| 6 months | +12.54% | ||
| Current year | +15.53% |
1 week
34.02
37.50
1 month
32.3039.50
Current year
26.0152.27
1 year
25.0252.27
3 years
9.1252.27
5 years
6.6952.27
10 years
5.0652.27
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 73 | 13-02-12 | |
Dolly Mandhan
CMP | Compliance Officer | - | 23-09-30 |
| Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 73 | 13-02-12 | |
| Director/Board Member | 66 | 13-07-28 | |
| Director/Board Member | 46 | 19-02-13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 36 | +1.12% | 2,279 |
| 24-05-30 | 35.6 | -0.59% | 5,633 |
| 24-05-29 | 35.81 | +2.17% | 2,387 |
| 24-05-28 | 35.05 | +0.14% | 3,085 |
| 24-05-27 | 35 | -2.78% | 3,570 |
Delayed Quote Bombay S.E., May 31, 2024 at 06:00 am
More quotes
Oxygenta Pharmaceutical Limited is an India-based company, which is primarily engaged in the manufacturing of bulk drugs and active pharmaceutical ingredients (API). The Company is also engaged in the business of manufacturing all classes and kinds of drugs, including pharmaceutical preparation, and organic fine chemicals. The Company has its manufacturing facilities situated at Survey no. 252/1, Aroor Village, Sadasivapet Mandal, Sangareddy District, Telangana State.
Sector
Pharmaceuticals
Calendar
2024-08-12
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +15.53% | 15.16M | |
| +40.73% | 734B | |
| +32.83% | 591B | |
| -6.30% | 350B | |
| +15.15% | 315B | |
| +4.05% | 276B | |
| +15.00% | 238B | |
| +9.78% | 206B | |
| -5.52% | 204B | |
| +6.17% | 161B |
- Stock Market
- Equities
- 524636 Stock
